Back to top

NanoViricides initiated with an Outperform at Noble Capital

Noble Capital initiated coverage of NanoViricides (NNVC) with an Outperform rating and $6 price target NanoViricides has a proprietary technology p...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: